Search clinical trials for: tirofiban hydrochloride (AGGRASTAT®)

Total 393 results

University of Iowa

Withdrawn

Clinical Trial to Evaluate the Safety of Continuous IV Tirofiban in Acute Ischemic Stroke (iTREMT)

Ischemic Stroke | Acute Ischemic Stroke

United States
David Hasan

Completed

Induced Suppression of Platelets Activity in Aneurysmal SAH Management (iSPASM)

Subarachnoid Hemorrhage, Aneurysmal

United States
Second Hospital of Jilin University

Unknown

Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease

Coronary Artery Disease

China
Hospices Civils de Lyon

Completed

GPIIbIIIa Inhibitors in the RESCUe and RESURCOR Networks at the Acute Myocardial Infarction (AGIR2)

Acute Myocardial Infarction

France
Medicure
SCRI Development Innovations, LLC

Completed

Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention (SAVI-PCI)

Myocardial Infarction | Unstable Angina | Acute Coronary Syndromes

United States
Medicure
SCRI Development Innovations, LLC

Withdrawn

Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention (ATLAST-PCI)

Myocardial Infarction | Percutaneous Coronary Intervention | Unstable Angina | Acute Coronary Syndromes
University of Bologna

Completed

FATA: Randomized Study on Facilitated Angioplasty With Tirofiban or Abciximab (FATA)

Acute Myocardial Infarction

Italy
Kosuyolu Heart Hospital
The Society of Cardiac Health Protection

Completed

Tirofiban Intracoronary Bolus-only Versus Intravenous Bolus Plus Infusion in STEMI Patients

Acute Myocardial Infarction
Medicure

Completed

Pharmacokinetic Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Varying Degrees of Renal Function

Renal Insufficiency

United States
Seoul National University Bundang Hospital

Completed

Tailored Use of Tirofiban for Non-ST-elevation Acute Coronary Syndrome Patients

Non-ST Elevation Myocardial Infarction
S. Anna Hospital

Completed

Safety of High-dose Tirofiban During Coronary Angioplasty (SANTISS)

Coronary Artery Disease

Italy
University Hospital Inselspital, Berne

Completed

Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI. (FABOLUS-FASTER)

Coronary Artery Disease | STEMI - ST Elevation Myocardial Infarction

Italy, Switzerland
Capital Medical University

Recruiting

Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke (TREND)

Acute Stroke

China
Beijing Tiantan Hospital
GrandPharma (China) Co., Ltd.

Recruiting

Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction (STRATEGY)

Branch Atheromatous Disease

China
Inova Health Care Services

Terminated

Antiplatelet Effects of Tirofiban vs. Cangrelor N-STEMI Patients Undergoing Percutaneous Coronary Intervention

Non-ST Elevation Myocardial Infarction (NSTEMI)

United States
The First Affiliated Hospital of Zhengzhou University
The First Affiliated Hospital of Henan University of Science and Technology; First Affiliated Hospital of Xinjiang Medical University and other collaborators

Unknown

Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI (NOSLOWFLOW-Ⅰ)

ST Segment Elevation Myocardial Infarction | Primary Percutaneous Coronary Intervention

China
The First Affiliated Hospital of Zhengzhou University
The First Affiliated Hospital of Henan University of Science and Technology; First Affiliated Hospital of Xinjiang Medical University and other collaborators

Unknown

Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI (NOSLOWFLOW-Ⅱ)

ST Segment Elevation Myocardial Infarction | Elective Percutaneous Coronary Intervention

China
Università degli Studi di Ferrara

Completed

Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse (FABOLUS PRO)

ST Segment Elevation Myocardial Infarction

Italy
Eisai Inc.

Terminated

Study to Evaluate the Efficacy and Safety of Belviq XR® in Conjunction With Lifestyle Modification for Weight Loss in Obese Adolescents, Age 12 to 17 Years

Obesity

United States
Genzyme, a Sanofi Company

Completed

Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer HCl Tablets in Haemodialysis Patients

Chronic Kidney Disease

United Kingdom
Galderma R&D

Completed

Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma

Basal Cell Carcinoma

Australia
University of Milan
Fondazione "Un Cuore per Milano" - a no profit foundation

Completed

Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 (PIC-19)

Pneumonia, Viral | Embolism and Thrombosis | Respiratory Failure | Corona Virus Infection

Italy
Telik

Terminated

Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS)

United States
Telik

Terminated

Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS)

United States
Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company

Completed

Prasugrel Switching Study in Patients With Acute Coronary Syndrome (ACS) Who Underwent Percutaneous Coronary Intervention (PCI)

Acute Coronary Syndrome (ACS)

Taiwan
Merck KGaA, Darmstadt, Germany
Smerud Medical Research International AS; Merck Serono Norway

Completed

Response to Kuvan® in Subjects With Phenylketonuria (PKU) in a 4 Weeks Testing Period (ENDURE)

Phenylketonuria

Norway
BioMarin Pharmaceutical

Completed

Kuvan®'s Effect on the Cognition of Children With Phenylketonuria (KOGNITO)

Phenylketonuria

Italy, Spain, United Kingdom, Germany
National University of Malaysia

Completed

Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients

Critical Illness | Hospital-acquired Pneumonia | Community-acquired Pneumonia | Severe Pneumonia

Malaysia
Peking Union Medical College Hospital
Pharmaron (Chengdu) Clinical Services Co., Ltd.

Recruiting

Efficacy and Safety of Tirofiban for Patients With BAD (BRANT) (BRANT)

Branch Atheromatous Disease

China
Telik

Terminated

Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

United States
Race Oncology Ltd
Astex Pharmaceuticals, Inc.

Withdrawn

A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS (BISECT)

Acute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Higher Risk Myelodysplastic Syndrome

Australia
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...

Completed

GXR RM China BE Study (Darmstadt - Jiangsu)

Healthy

Germany
Genzyme, a Sanofi Company

Completed

Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis

Kidney Diseases | End-Stage Renal Disease | Chronic Renal Insufficiency

United States
Eli Lilly and Company

Completed

A Relative Bioavailability Study of a Prasugrel Orally Disintegrating Tablet

Sickle Cell Disease

United States
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...

Completed

GXR RM (Glucophage® Extended Release Reduced Mass) 500 Milligram (mg) Korea Bioequivalence (BE) Study

Healthy

Korea, Republic of
Genzum Life Sciences

Completed

BE Study of Naftifine HCL

Tinea Pedis

United States, Dominican Republic
Taro Pharmaceuticals USA

Completed

Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea Pedis

Tinea Pedis
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study of Bendamustine in the Treatment of Chinese Participants With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab Treatment

Non-Hodgkin Lymphoma

China
Merck KGaA, Darmstadt, Germany

Completed

Phase 3 Open-label Study to Evaluate the Response and Safety of Kuvan® in Subjects With Phenylketonuria

Phenylketonuria

Germany
AstraZeneca

Terminated

Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan

Cancer | Advanced Solid Tumors | Advanced Solid Malignancies

United States
Boehringer Ingelheim

Completed

Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride

Healthy
Hallym University Kangnam Sacred Heart Hospital

Completed

Effects of Oral Mucolytics on Tear Film and Ocular Surface

In the Present Study, we Investigated the Effects of Oral Ambroxol on Tear Film and Ocular Surface.

Korea, Republic of
Shanghai University of Traditional Chinese Medicine
Shanghai Chest Hospital; Shanghai Pulmonary Hospital, Shanghai, China

Completed

Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma

Cancer
Juno Therapeutics, Inc., a Bristol-Myers Squibb...
Celgene Corporation

Withdrawn

A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies

Leukemia, Lymphocytic, Chronic, B-Cell

United States, Austria, Belgium, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, United Kingdom
Astellas Pharma Europe B.V.

Completed

Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms (Neptune)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Belgium, Italy, France, Austria, United Kingdom, Netherlands, Hungary, Russian Federation, Poland, Slovakia, Czech Republic, Belarus, Germany
Boehringer Ingelheim

Completed

The Study Observes How Long Patients With Non-small Cell Lung Cancer (NSCLC) Benefit From Treatment With Epidermal Growth Factor Tyrosine Kinase Inhibitor (EGFR-TKI) When Given Either for Uncommon Mutations or for Common Mutations in the Sequence Afatinib Followed by Osimertinib (UpSwinG)

Non-squamous, Non-Small Cell Lung Cancer

United Kingdom
Cephalon

Completed

Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

United States
Emory University
National Center for Complementary and Integrative Health (NCCIH); Children's...

Recruiting

Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease (R34 pK/PD)

Sickle Cell Disease

United States
Denovo Biopharma LLC

Completed

Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™

Diffuse Large B-Cell Lymphoma

United States, China
Boehringer Ingelheim

Completed

Antistax® in Patients With Chronic Venous Insufficiency

Venous Insufficiency

Search clinical trials for: tirofiban hydrochloride (AGGRASTAT®)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations